SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-000364
Filing Date
2023-01-06
Accepted
2023-01-06 17:30:31
Documents
16
Period of Report
2023-01-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K atha-20230106.htm   iXBRL 8-K 74015
2 EX-1.1 atha-ex1_1.htm EX-1.1 496410
3 EX-5.1 atha-ex5_1.htm EX-5.1 21034
4 GRAPHIC img222338278_0.jpg GRAPHIC 10051
5 GRAPHIC img222338278_1.jpg GRAPHIC 5753
  Complete submission text file 0000950170-23-000364.txt   809709

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT atha-20230106.xsd EX-101.SCH 2446
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT atha-20230106_pre.xml EX-101.PRE 11790
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT atha-20230106_lab.xml EX-101.LAB 14441
10 EXTRACTED XBRL INSTANCE DOCUMENT atha-20230106_htm.xml XML 4888
Mailing Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011
Business Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011 (425) 620-8501
Athira Pharma, Inc. (Filer) CIK: 0001620463 (see all company filings)

IRS No.: 453368487 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39503 | Film No.: 23516056
SIC: 2836 Biological Products, (No Diagnostic Substances)